Access, use and disposal of antimicrobials among humans and animals in Wakiso district, Uganda: a qualitative study by Musoke, D et al.
Musoke et al. J of Pharm Policy and Pract           (2021) 14:69  
https://doi.org/10.1186/s40545-021-00361-4
RESEARCH
Access, use and disposal of antimicrobials 
among humans and animals in Wakiso district, 
Uganda: a qualitative study
David Musoke1* , Carol Namata1, Grace Biyinzika Lubega1, Freddy Eric Kitutu2, Lawrence Mugisha3, 
Saba Amir4, Claire Brandish5, Joviah Gonza1, Deborah Ikhile6, Filimin Niyongabo1, Bee Yean Ng5, 
Jean O’Driscoll5, Kate Russell‑Hobbs5, Jody Winter7 and Linda Gibson6 
Abstract 
Background: Inappropriate use of antimicrobials in both humans and animals is a key driver of antimicrobial resist‑
ance (AMR). In addition, human behaviours such as poor disposal of antimicrobials in the environment can increase 
their exposure to microbes which can impact on humans and animals. However, evidence on access, use and disposal 
of antimicrobials for humans and animals at community level in Uganda is limited. This study therefore explored 
access, use and disposal of antimicrobials among humans and animals in Wakiso district, Uganda.
Methods: A qualitative study was conducted that involved focus group discussions (FGDs) and key informant inter‑
views (KIIs). Participants of the FGDs were community health workers (CHWs) and farmers involved in animal hus‑
bandry, while key informants included: officials from the Ministry of Health; Ministry of Agriculture, Animal Industry 
and Fisheries; human and animal health professionals; district health officials; and members of the national AMR sur‑
veillance committee. Twelve FGDs were held (8 for CHWs and 4 for farmers) while 15 KIIs were conducted. Thematic 
analysis in NVivo (version 12) was performed.
Results: Five main themes emerged from the study: access to antimicrobials in humans; access to antimicrobials in 
animals; use of antimicrobials in humans; use of antimicrobials in animals; and disposal of antimicrobials. Community 
members mainly accessed antimicrobials for humans from public health facilities such as government health centres, 
as well as private facilities, including drug shops and clinics. Antimicrobials for animals were obtained from veterinary 
practitioners and drug shops (both for humans and veterinary). Examples of inappropriate use of antimicrobials in 
both humans and animals was evident, such as sharing antibiotics among household members, and giving human‑
prescribed antimicrobials to food‑producing animals as growth promoters. While some CHWs returned unused anti‑
microbials to public health facilities for proper disposal, community members mainly disposed of antimicrobials with 
general household waste including dumping in rubbish pits.
Conclusions: There is a need to increase awareness among the population on proper access, use and disposal of 
antimicrobials for both humans and animals. Development of a drug disposal system at community level would 
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Introduction
Access to antimicrobials has generated impressive 
improvements in global health in recent years especially 
in low- and middle-income countries (LMICs). The sig-
nificant reduction in morbidity and mortality from 
infectious diseases has been linked in part to increased 
access and use of antimicrobials [1–3]. However, inap-
propriate use and exposure of antimicrobials in humans, 
animals and the environment is thought to be one of the 
key drivers of antimicrobial resistance (AMR). Antibiot-
ics are among the most misused medicines around the 
world due to their ubiquitous availability, affordability 
and perceived safety, which has contributed to the grow-
ing public health crisis of AMR [4]. Although the emer-
gence of AMR is an inevitable consequence of antibiotic 
use, misuse and overuse of antibiotics accelerates the 
process of AMR development, limiting the useful lifespan 
of available drugs for the treatment of bacterial infections 
[5]. Globally, approximately 700,000 people die from 
antimicrobial-resistant infections every year, and AMR-
related mortality is predicted to rise to 10 million per 
year by 2050 [6]. It has been reported that the majority 
of the world’s annual 5.7 million antimicrobial-treatable 
deaths occur in LMICs [7, 8]. In many LMICs including 
Uganda, infections such as gonorrhoea, tuberculosis, 
bacterial bloodstream infections, urinary tract infections, 
and foodborne diseases have become increasingly diffi-
cult to treat leading to increased risk of spreading resist-
ant infections, higher treatment costs, and increased risk 
of death [4, 7, 9, 10]. Although AMR is a global challenge, 
its effects are likely to be felt most acutely in LMICs 
constrained with insufficient health infrastructure, chal-
lenges with infection prevention and control, insufficient 
access to alternative treatment options, as well as inad-
equate human and financial resources to counter drug-
resistant infections [11].
Access to antimicrobials by households is largely 
dependent on geographical location in relation to health 
service providers and economic status. The Uganda 
Health Sector Development Plan 2015/16–2019/20 
indicated that only 72% of households live within 5  km 
of a health facility [12]. Although this is indicative of a 
geographical improvement in access to health services 
compared to previous years, affordability of services 
remains a limiting factor. The primary sources of health 
care financing are individual households out-of-pocket 
expenditure (37%), donors (45%) and government (15%) 
[12, 13]. Despite the accessibility and financial chal-
lenges, there are reports of high and unnecessary use of 
antimicrobials among patients. Examples of such prac-
tices include use of antimalarials for fevers not asso-
ciated with malaria, as well as use of antibiotics for 
non-bloody diarrhoea and non-pneumonia upper res-
piratory infections that are commonly caused by viruses 
[14]. Uganda has also reported resistance against com-
monly used antimicrobials including ampicillin, cipro-
floxacin and ceftriaxone used for bacterial infections, 
artemether–lumefantrine commonly used for malaria, 
as well as rifampicin and isoniazid used for tuberculosis 
[10, 15]. Consequently, second- or third-line antimicrobi-
als, which are more expensive and not readily available in 
health facilities, might be required to treat these common 
infections [12, 16].
Antimicrobials in Uganda are categorized under Class 
B by the National Drug Authority (NDA)—the regula-
tory body for medicines in Uganda—hence these require 
a prescription before being dispensed. However, in prac-
tice, many of them are easily attainable from drug outlets 
such as pharmacies and drug shops without a prescrip-
tion [10]. Self-medication and premature discontinua-
tion of antimicrobials has also been observed in Uganda 
contributing to the development of AMR [9, 10]. These 
undesirable practices are drivers of the growing drug 
resistance of microorganisms across the country. In the 
animal industry, misuse and consumption of antimi-
crobials is rampant and estimated to be higher than in 
human health [17]. This is because over the past 60 years, 
antibiotics have been used in animal feed at sub-thera-
peutic doses to improve animal performance and for feed 
efficiency, in addition to their use for treating infections 
[18]. The need for in-feed antibiotics as growth promot-
ers has been driven by the demand for animal protein 
sources due to the rapidly increasing human population 
leading to higher antimicrobial usage in animal farming 
[19]. Without the use of antimicrobials, especially antibi-
otics, production costs would be higher with lower yield 
[20]. However, antibiotic use in animals is poorly docu-
mented for many LMICs, and this is exacerbated by weak 
enforcement of policies on antimicrobial use [15]. In 
Uganda, farmers often self-prescribe antibiotics for their 
animals when they fall ill and purchase them from vet-
erinary drug shops without the directives of veterinarians 
facilitate improved waste management of antimicrobials. Together, these measures would help prevent the rate of 
progression of AMR in communities.
Keywords: Antimicrobial resistance, Antimicrobials, Antimicrobial stewardship, Community, Humans, Animals, One 
Health, Waste management, Uganda
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or a prescription [10]. In addition, it has been reported 
that some farmers administer human-prescribed antiret-
roviral drugs to livestock as ‘immune boosters’ [21]. Such 
use of antimicrobials in food animals carries additional 
risks to human health because resistant microbes and 
antimicrobial residues have been found in both living 
and ready-to-eat animal products [19, 22]. In addition, 
antimicrobial residues are extensively found in the envi-
ronment including soil and water [20]. Environmental 
exposure of microbes to antimicrobials is aggravated by 
their poor disposal particularly in LMICs [23]. Inappro-
priate disposal of antimicrobials such as dumping in the 
environment together with other household waste has 
also been documented in several studies [24–26].
Antimicrobials and their residues can be found almost 
everywhere in the environment, and antimicrobial-resist-
ant organisms continue to interact between humans, 
animals and the environment [20]. This emphasizes the 
need for a One Health approach when tackling AMR 
globally but especially in LMICs including Uganda. The 
Government of Uganda has increased attention to pro-
moting Antimicrobial Stewardship (AMS) in recent years 
including development of an AMR National Action Plan 
(NAP) [9]. The NAP emphasizes the need to strengthen 
the evidence base on antimicrobial use to inform policy 
including through research [9]. However, most of the 
research on AMS in the country to date has been from 
large health facilities [27–29], with minimal literature 
from community settings. Given that AMR is a complex 
public health problem that concerns many sectors, there 
is need for more evidence on access and use of antimicro-
bials among humans and animals particularly in the com-
munity, as well as disposal of antimicrobials at household 
level. Such evidence is key to inform medical, veterinary, 
environmental and other professionals as well as policy 
makers on preventing the further development of AMR 
through a One Health approach. The use of qualitative 
methods is particularly important to critically examine 
behaviours and practices of the community regarding 
antimicrobials which may not be achieved quantitatively. 
In addition, qualitative research enables deeper explora-
tion of concerns and understanding of myths regarding 
antimicrobials established by other studies. Therefore, 
this study qualitatively explored access, use and disposal 




The qualitative study conducted in Wakiso district 
used focus group discussions (FGDs), and Key Inform-
ant Interviews (KIIs) to explore access, use and disposal 
of antimicrobials among humans and animals in the 
community. Participants of the FGDs were community 
health workers (CHWs) and farmers involved in animal 
husbandry who were purposively selected in consulta-
tion with village leaders and community mobilisers in 
the study area. CHWs were involved in the study as they 
are the first point of contact of the community with the 
health system and are normally knowledgeable about 
health-related issues in their locality. In addition, many 
CHWs are involved in providing treatment for malaria, 
pneumonia and diarrhoea in their villages among chil-
dren under 5  years of age under integrated community 
case management of childhood illnesses. Some CHWs 
own animals therefore they can also share their experi-
ences on use of antimicrobials in animals in their house-
holds. Farmers involved in animal husbandry were 
included in the study to provide their experiences on 
access and use of antimicrobials for their animals, as well 
as for themselves and other household members. Twelve 
mixed-gender FGDs, each comprising 8 participants, 
were conducted, with 8 among CHWs and 4 among 
farmers. A total of 15 key informants were purposively 
selected based on their expertise and relevance to AMR 
and AMS for both human and animal health at national, 
sub-national and local levels. These included: health pro-
fessionals from public and private health facilities; veteri-
nary practitioners; members of the Wakiso district health 
office; Ministry of Health officials from the pharmacy and 
health promotion departments; Ministry of Agriculture, 
Animal Industry and Fisheries officials; and members of 
the national AMR surveillance committee. The 12 FGDs 
and 15 KIIs were sufficient to reach data saturation.
Study area and setting
The study was carried out in Kajjansi and Kasanje town 
councils in Wakiso district, Uganda, for the FGDs. 
However, the KIIs involved national-level stakeholders 
beyond the district. These town councils were purpo-
sively selected for their involvement in the study as they 
have a good representation of peri-urban and rural com-
munities, and are highly involved in animal husbandry. 
Wakiso is the most populated district in Uganda with a 
population of 2,007,700 as per the 2014 national census 
and an estimated annual growth rate of 4.1% [13]. The 
district consists of four municipalities, seven sub-coun-
ties and eight town councils. The district includes both 
urban and rural areas, with half of its population living in 
urban settings [13]. Wakiso district has 589 health facili-
ties, comprising 72 government, 477 private-for-profit, 
and 40 private not-for-profit facilities [30]. Kajjansi town 
council has 3 government health facilities (one health 
centre II, one health centre III, and one health centre IV) 
while Kasanje town council has only one government 
health facility (health centre III). Both town councils have 
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several private health facilities including health centres, 
clinics, pharmacies and drug shops which are all involved 
in health service delivery including dispensing antimicro-
bials. The district has government veterinarians who are 
mandated to oversee and support farmers in the com-
munity. In addition, Wakiso district has several private 
veterinarians who are involved in managing illness in ani-
mals. Wakiso’s proximity to Kampala, the country’s capi-
tal city, provides easy access to antimicrobials that may 
be unavailable or more expensive within the district.
Data collection
FGD and KII guides were used to collect data from the 
respective participants. These tools were developed fol-
lowing a comprehensive literature review on antimicro-
bial access, use and disposal in Uganda and other LMICs. 
The tools were piloted in a village in Kajjansi that was 
not involved in the actual study. Specifically, the tools 
assessed for both humans and animals: sources of antimi-
crobials (private and public sectors, markets, veterinary 
officers, and drug shops/pharmacies); ease of access to 
antimicrobials; self-prescription; free versus paid for anti-
microbials; duration of consumption of antimicrobials; 
sharing of antimicrobials between household members 
and different animals; use of left-over antimicrobials; and 
disposal of expired/unused antimicrobials. The guides 
were developed in English, and later translated to 
Luganda, the local language most used in the study area. 
All FGDs were conducted in the local language and facili-
tated by two members of the research team who were 
experienced in qualitative research. One of the members 
moderated the discussions while the other helped with 
notetaking as well as audio recording of the proceedings. 
The KIIs were conducted by one of the researchers who 
audio recorded them. Most of the KIIs were conducted 
in English, except for a few held in the local language. For 
Kajjansi, the FGDs were held at a project field office in 
the area, while in Kasanje, the home of a village chairper-
son was used. KIIs were scheduled by telephone appoint-
ment to ensure that the participants were available to 
take part. The key informants suggested the appropriate 
date, time and location for the interviews which were 
predominantly held at their workplaces including health 
facilities and offices. The FGDs and KIIs were conducted 
concurrently. While the FGDs lasted between 30 and 
60 min, the KIIs took between 20 and 40 min.
Data management and analysis
All audio recordings of the FGDs and KIIs were tran-
scribed verbatim in the appropriate language (English or 
Luganda) by one of the researchers involved in data col-
lection. Two researchers read the transcriptions to ensure 
they were a true representation of the data collected. 
Once the transcripts were validated, those in Luganda 
were translated to English by one of the researchers. All 
transcribed data were then transferred to NVivo (ver-
sion 12) for analysis. Data from the FGDs and KIIs were 
analysed together since the two data collection methods 
were used for the same research question. However, data 
from each of the methods was clearly identifiable during 
data analysis. Indeed, the results presented in the manu-
script highlight which findings came from the FGDs or 
KIIs. During data analysis, the imported texts were read 
which helped the researchers to further appreciate the 
data, which was then analysed by data coding. Data cod-
ing involved identifying and extracting passages of text 
from the transcripts into nodes. These nodes were cre-
ated in NVivo to represent each text of the transcript as 
a code. To code a chunk of data under a node in each 
transcript, the text was highlighted and pulled to the 
identified free node. In some cases, multiple nodes were 
assigned to the same chunk of text. After coding the text, 
a search was conducted to find connections between the 
various nodes. Similar nodes were identified and grouped 
together conceptually to form tree nodes, and each tree 
node was designated as a sub-theme. Using thematic 
analysis, the tree nodes were then grouped together into 
5 main themes. These themes are employed to present 
the major findings of the study.
Ethical considerations
Ethical approval for the study was obtained from Mak-
erere University School of Health Sciences Research 
and Ethics Committee (2019-051). The study was also 
approved and registered by the Uganda National Council 
for Science and Technology (HS 2711). All participants 
provided written informed consent before taking part in 
the study. Data were only accessed by the research team 
and used solely for purposes of the study.
Results
The results of this study are presented under 5 main 
themes that emerged from the FGDs and KIIs: access to 
antimicrobials in humans; access to antimicrobials in ani-
mals; use of antimicrobials in humans; use of antimicro-
bials in animals; and disposal of antimicrobials. The study 
established that community members accessed antimi-
crobials for humans mainly from public health facilities 
such as government health centres, as well as private 
facilities including drug shops and clinics. Antimicrobials 
for animals were obtained from veterinary practitioners 
and drug shops (both for humans and veterinary). The 
study found inappropriate use of antimicrobials for both 
humans and animals, such as sharing antibiotics among 
household members, and giving human-prescribed 
antimicrobials to food-producing animals as growth 
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promoters. In addition, it was established that while 
there was disposal of unused antimicrobials at public 
health facilities by CHWs, community members mainly 
disposed of antimicrobials as part of general household 
waste including dumping in rubbish pits.
Access to antimicrobials in humans
Public health facilities
CHWs and farmers reported that they accessed antimi-
crobials from public health facilities such as government 
health centres. It was revealed that these centres pre-
scribed antimicrobials to patients after making a clinical 
assessment and diagnosis. In addition, it was reported 
that antimicrobials for sick children aged below 5  years 
were also accessed from CHWs who are involved in treat-
ment of childhood illnesses of malaria, pneumonia and 
diarrhoea.
“Most of the time, we go to Nakawuka government 
health centre where they give us medicine after con-
ducting a medical check-up. That is why we go to 
Nakawuka because of the assurance that they will 
write a prescription after carrying out some medical 
tests which is not always the case elsewhere.” CHW, 
participant 3, FGD 11
Although most CHWs and farmers reported access-
ing antimicrobials from government health facilities, 
they faced various challenges whilst doing so, including 
travelling long distances. Despite the government health 
facilities providing antimicrobials free of charge, many 
community members found the high transport costs 
incurred to get to the facilities prohibitive. As such, some 
individuals resorted to obtaining antimicrobials from 
alternative sources.
“Distance is a big challenge because I stay in Buswa 
and the government health centre is in Mpumudde 
so it makes it hard for me to go there for health care. 
If I ask a boda boda [commercial motorcycle] rider 
to take me to the health centre and back, they may 
ask for three thousand shillings [approximately USD 
0.8] which I may not have. Therefore, if I have no 
money for transport, I give up and resort to other 
options.” CHW, participant 1, FGD 9
Another challenge faced by community members 
established from the FGDs were the long waiting times 
reported at government health facilities before being 
attended to by health professionals. Participants reported 
that they sometimes spent a lot of time waiting to see 
health workers only to be referred to alternative places 
that had the recommended drugs due to regular stock-
outs at the facilities. This led to participant perceptions 
that public health facilities could not guarantee the 
availability of necessary medicines. Therefore, instead of 
waiting at the public facilities, some participants said that 
they visited alternative places where they quickly got the 
required service hence saving time for work and other 
activities.
“Truth be told, I do not go to public health centres 
for medication. I cannot waste my time standing 
in a long queue just to get paracetamol and then 
be told to go buy the rest of the medication from 
a pharmacy. I am a parent and have to meet the 
needs of my family such as school fees. So, I would 
rather get some little money and go to a pharmacy 
or drug shop to buy drugs in the shortest time possi-
ble so I can spare time to attend to my family needs.” 
Farmer, participant 5, FGD 6
Private health facilities
From the FGDs, community members accessed anti-
microbials from private health facilities such as clinics, 
pharmacies and drug shops. They accessed these facilities 
mainly because many were located near their homes, and 
there was more confidence that they would have stock of 
antimicrobials, perceived to be frequently unavailable at 
government health facilities. It was established that pri-
vate health facilities also offered shorter waiting times to 
get a service compared with government facilities.
“When community members visit the government 
health facility and find no drugs, the next time they 
fall sick they do not return to the facility as they still 
think that it’s not worth it as they may still find no 
drugs. Therefore, they often ignore the option of vis-
iting the health facility again for medical help and 
instead go to private clinics and drug shops.” CHW, 
participant 2, FGD 1
From the experience of CHWs and farmers who 
accessed government health facilities where antimicro-
bials were unavailable, they were always given prescrip-
tions to enable them to purchase the required medicines 
from private health facilities. Therefore, the unavailability 
and stock-out of certain antimicrobials at government 
health facilities promoted purchase of drugs from private 
providers.
“In some communities, it is very hard to access 
medicines from government health centres as they 
are rarely available there so most people resort to 
drug shops or pharmacies. The health workers at 
the health centre write prescriptions for us to get the 
unavailable medicines from private pharmacies.” 
Farmer, participant 3, FGD 4
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Although the FGDs established that community mem-
bers routinely accessed antimicrobials from private 
health facilities, they were faced with the challenge of 
high cost. Indeed, many participants reported that they 
could not always afford to purchase a complete course 
of antimicrobials from private health facilities. As such, 
they sometimes purchased inadequate doses depend-
ing on their financial ability, and as soon as the disease 
symptoms subsided, some never returned to purchase 
the remaining doses. In addition, it was established that 
many private providers such as drug shops issued anti-
microbials to community members without any pre-
scription or medical investigation. This situation was 
reportedly further exacerbated by the need to make profit 
in the private sector.
“We strive to get the complete dosage from the drug 
shops. But in case there is not enough money, we first 
buy what we can afford, and then buy the rest when 
we get more money. This means that in case the 
money is not obtained at the appropriate time, one 
will not get the whole dosage as it is supposed to be.” 
CHW, participant 8, FGD 8
Access to antimicrobials for animals
Veterinary practitioners
Most farmers reported that they accessed antimicrobials 
for their animals from private veterinary practitioners. It 
was revealed that these were mainly mobile veterinary 
practitioners who travelled from village to village treat-
ing animals. However, some of these practitioners lacked 
adequate diagnostic equipment for the animals which 
increased the risk of misdiagnosis. Farmers also reported 
that private veterinary practitioners were expensive 
which was a major hindrance to using their services. 
However, since the public veterinary practitioners as part 
of local government were inactive, community members 
had no choice but to opt for the expensive private veteri-
nary workers.
“In my community, there are government public vet-
erinary practitioners. However, the ones who were 
assigned to our village are very inactive as they 
hardly ever check on our sick animals. Therefore, 
when our animals fall sick, we have to call a pri-
vate veterinary practitioner who is very expensive.” 
Farmer, participant 1, FGD 10
Veterinary drug shops
Farmers reported that they accessed antimicrobials for 
their animals from veterinary drug shops often with rec-
ommendations from veterinary practitioners. However, 
it was established that there were few veterinary drug 
shops in their communities. As such, farmers faced a 
challenge of travelling long distances to access some of 
these drug shops. It was also noted that at times antimi-
crobials purchased from these facilities were found to be 
expired hence affecting their effectiveness in treating ani-
mal infections.
“For animal antimicrobials, we have to travel long 
distances for example to Mpigi to find veterinary 
drug shops where they are sold. However, some-
times the drugs are expired and cannot be effective 
in treating the animal diseases even after travelling 
such a long distance to access them.” Farmer, partici-
pant 2, FGD 4
Some farmers revealed that they used previous pre-
scriptions from veterinary practitioners to purchase 
antimicrobials from veterinary drug shops. This was 
partly because the farmers believed that they had gained 
enough experience in managing their animals for many 
years. Therefore, they did not feel it necessary to seek 
advice from veterinary practitioners anymore. However, 
it was reported by the key informants that farmers who 
purchased antimicrobials without consulting veterinary 
practitioners often gave the wrong doses to their ani-
mals. This was evidenced when the veterinary profes-
sionals interacted with farmers during their visits to the 
community.
“We used to buy antimicrobials from veterinary 
drug shops in our village. Although over the years, 
we got to know the common drugs used to treat our 
animals. Therefore, we don’t call veterinary practi-
tioners anymore but use previous prescriptions to 
buy drugs for our sick animals.” Farmer, participant 
8, FGD 6
Human drug shops
From the FGDs, some participants reported that they 
accessed antimicrobials for their animals from drug 
shops selling medicines primarily for humans. Farm-
ers revealed that they purchased and used antimicrobi-
als prescribed for humans after receiving testimonies 
from fellow farmers that they were effective in treating 
animal infections. Additionally, farmers reported that 
they sometimes accessed antimicrobials for their animals 
from human drug shops due to proximity to their homes 
in comparison to veterinary drug shops. As such, they 
did not need to travel long distances, costing the farmers 
less in terms of travel costs and time, to access antimicro-
bials for use among their animals.
“The animal drug shops are not readily accessible, 
and it is now common knowledge that medicines 
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given to humans can be used to treat animals. So 
instead of moving a long distance to the animal drug 
shops, we buy antimicrobials that we use when we 
are sick from human drug shops which have proved 
to yield positive results in treating animal diseases.” 
Farmer, participant 2, FGD 6
Use of antimicrobials in humans
Inappropriate use of antimicrobials by community members
The study established that most community members 
used antimicrobials inappropriately. For instance, some 
FGD participants reported that they shared antimicro-
bials with other family members in case more than one 
person in the household was sick. In addition, the shar-
ing of antimicrobials was reported as a common practice 
among children of the same household whose parents or 
guardians could not afford to purchase complete courses 
for each sick member of the family.
“I may go to the drug shop and buy medicine for my 
sick child and on reaching home, I find that another 
child is sick. I therefore immediately share the medi-
cine among the sick children because there is nothing 
else I can do at that moment with no funds to buy 
another dose.” Farmer, participant 6, FGD 10
Another improper practice by community members 
was self-medication. Instead of visiting health profes-
sionals for diagnosis and prescription, it was established 
from the KIIs that many community members self-pre-
scribed antimicrobials to treat self-diagnosed symptoms 
and conditions. It was therefore believed that as a result, 
patients often consumed unnecessary or inappropriate 
courses of antimicrobials. It was further established that 
some community members who self-medicated used 
previous prescriptions to purchase antimicrobials with-
out recommendation from a health worker.
“Self-medication is very common because a patient 
can come here and I prescribe for them antimicrobi-
als, and the next time that person is sick, they will 
not come. They will use the same labelled packet if 
they have the same symptoms to purchase the same 
drug from a private health facility.” Health practi-
tioner, Kajjansi Health Centre IV
From the KIIs, self-medication by community members 
was also noted to result in drug overuse. As an example, 
it was established that there was misuse of antibiotics 
such as amoxicillin by community members.
“For some people, you find that even if they do not 
need antibiotics, they still access and use them. They 
keep saying, ‘For me, if I do not swallow that medi-
cine [amoxicillin], I will not get better’. So, they make 
it a habit to take such antimicrobials even when not 
necessary.” Health practitioner, Kasanje Health Cen-
tre III
Consumption of incomplete courses of antimicrobi-
als was also practised by community members. It was 
established from the FGDs and KIIs that some commu-
nity members discontinued the course of antimicrobials 
in cases where their symptoms subsided. Whereas some 
community participants reported disposing of the left-
over antimicrobials, others kept them for future use in 
case of recurring infection or if another family member 
presented with the same symptoms. Some FGD partici-
pants reported discontinuation of the course of antimi-
crobials due to busy work schedules. It also emerged that 
some community members discontinued medication 
because of side effects.
“I take the medication as prescribed, but as soon 
as I feel better, I keep the rest for future use when I 
become sick again or when another family member 
becomes sick. This is a common practice within our 
community.” Farmer, participant 6, FGD 6
Use of antimicrobials in animals
Improper use of antimicrobials among animals
It was established that some farmers offered incom-
plete courses of antimicrobials to their animals. This 
was because when the symptoms of their sick animals 
decreased, farmers withdrew medication and kept it for 
use in case of future infections. However, it was reported 
by the key informants that some farmers tended to unin-
tentionally overdose their animals due to not following 
instructions from veterinary practitioners. This was evi-
denced when the veterinary workers interacted with the 
farmers on various occasions. As such, overdosage was 
believed to contribute to accumulation of antimicrobial 
residues in animal food products such as meat which was 
later sold for human consumption.
“Another problem we find is that some farmers over-
dose the animals unknowingly hence you find that 
the meat has high amounts of drug residues, yet they 
continue to sell or consume such products them-
selves which is not a good practice.” Veterinary prac-
titioner, Kajjansi town council
Use of human antimicrobials in food‑producing animals
It was established from the KIIs that some farmers used 
antimicrobials prescribed for humans in food-producing 
animals for non-pharmaceutical purposes. Key inform-
ants reported that human antimicrobials particularly 
antibiotics were used to preserve animal products such as 
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meat meant for human consumption. It was also estab-
lished that some community members added human-
prescribed antimicrobials, such as antiretroviral drugs to 
animal feeds for growth promotion especially for pigs.
“There are people who actually use human pre-
scribed drugs in animals. You may find somebody 
who is HIV positive and thinks the antiretrovirals 
are also good for their animals so they go ahead 
and give some of the drugs to pigs to enhance their 
growth.” Veterinary practitioner 1, Wakiso district
Disposal of antimicrobials
Household disposal
Regarding disposal of antimicrobials, it was reported 
from the FGDs that community members disposed of 
left-over, unused, unwanted and expired antimicrobials 
together with general waste for example in rubbish pits 
located in their homes. The study also established that 
such antimicrobials were sometimes burned or dumped 
in the bush together with other household waste. Some 
participants explained that disposal of antimicrobials 
in rubbish pits or the bush had the potential for them 
being accessed by children, which could lead to adverse 
health effects if ingested. As such, participants suggested 
changes to how antimicrobials were disposed of includ-
ing using pit latrines or burying them to ensure they were 
out of children’s reach.
“In case of spoiled or expired drugs, it is better to dig 
up a hole in the ground and bury them or throw in 
a pit latrine rather than throwing them around the 
compound or the bush which could predispose chil-
dren to the risk of intoxication.” Farmer, participant 
6, FGD 4
Disposal at public health facilities
Some CHWs reported that they took unwanted or 
expired antimicrobials to government health facilities for 
final disposal. However, disposal at government facili-
ties was limited to CHWs who were involved in treat-
ment of childhood illnesses. These CHWs reported that 
they received safety boxes from government health facili-
ties. These boxes were used to store expired, left-over or 
spoilt antimicrobials, and other medical waste such as 
used malaria Rapid Diagnostic Test (RDT) kits. When 
these safety boxes became full, they were returned to the 
nearby government health facility for safe disposal of the 
waste.
“Some of us were given safety boxes where we keep 
the spoilt medicines. When the box gets full, one 
takes the responsibility to return it to the govern-
ment health centre for disposal. The medicines we 
dispose in the boxes include both personal ones and 
those we use for treatment of sick children in the 
community.” CHW, participant 2, FGD 12
Discussion
Global improvements in the use of antimicrobials have 
resulted in substantial gains in health care delivery [2]. 
Increased access to antimicrobials remains a crucial 
component in the management of infectious diseases. 
However, misuse of antimicrobials in both humans and 
animals has contributed to the global challenge of AMR 
which remains a grave public health threat. This study, 
which explored access, use and disposal of antimicrobials 
among humans and animals in Wakiso district, Uganda, 
showed that while antimicrobials for human use are free 
at public facilities, community members routinely used 
private facilities due to health system challenges plagu-
ing the public centres. Regarding access to antimicrobials 
for use in animals, the study established that these were 
predominantly obtained from private facilities, including 
veterinary practitioners, as well as veterinary and human 
drug shops. Consistent with existing evidence [31, 32], 
our study further demonstrated inappropriate use and 
disposal of antimicrobials both in humans and animals in 
the community. These findings provide evidence on anti-
microbial use as recommended by the Uganda AMR NAP 
and demonstrate the need for a One Health approach in 
ensuring effective access and use of antimicrobials in 
both humans and animals. This recognition of the need 
for a One Health approach in addressing the misuse of 
antimicrobials in the fight against AMR has been previ-
ously articulated by Musoke et al. [33] and Pokharel et al. 
[34]. In addition, our findings emphasize the importance 
of implementing the World Health Organization (WHO) 
global recommendations for containment of AMR such 
as improving use of antimicrobials, reducing the use of 
antimicrobials in food-animal production, and improving 
access to appropriate antimicrobials [35].
Our study revealed that access to antimicrobials is 
partly provided through the public primary health care 
system, including government health centres and CHWs 
at no cost to patients. Although access to antimicrobi-
als from public facilities is usually given after a clinical 
assessment and diagnosis as found in our study, this is 
limited by various health system challenges. Similar to 
our findings, other studies have also shown that chal-
lenges such as stock-out of essential medicines, long 
distances between community dwellings and health facil-
ities, high cost of transportation to facilities, and long 
waiting times restrict access to antimicrobials in the pub-
lic health sector [36, 37]. The role of CHWs in dispensing 
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antimicrobials addresses some of these challenges since 
they work closer to the communities. However, CHWs 
only manage three diseases—pneumonia, malaria and 
diarrhoea—and only among children under 5  years of 
age as part of integrated community case management 
of childhood illnesses. In addition, CHWs in Uganda also 
face regular stock-out of antimicrobials [38, 39]. These 
challenges are not specific to antimicrobials, but reflect 
the general constraints on primary health care services in 
Uganda and other LMICs [40]. Addressing these health 
system challenges by key stakeholders such as the Min-
istry of Health would increase access to antimicrobials at 
public health facilities.
Our study established that the challenges in accessing 
antimicrobials from the public health sector led commu-
nity members to resort to private health facilities includ-
ing drug shops, clinics and pharmacies. Private facilities 
are crucial for access to essential medicines in LMICs 
including Uganda [41]. However, as our study revealed, 
access to antimicrobials from private facilities presents 
other concerns. The most prominent disadvantage is the 
out-of-pocket cost to individuals associated with the pri-
vate sector [7] which implies that although antimicrobials 
may be available, community members may face finan-
cial constraints accessing them. This may in turn result 
in an insufficient course of antibiotic being afforded. In 
addition, unlike public facilities which only provide anti-
microbials after medical examination and diagnosis, the 
study revealed that private facilities provide antimicrobi-
als without necessarily doing appropriate clinical assess-
ment nor having a prescription. This practice is common 
in LMICs and can be attributed to poor regulation of 
access to antimicrobials [7]. For example, extensive use 
of antimicrobials without prescription has been reported 
in other LMICs such as Bangladesh and Sudan [32] and 
Ethiopia [31, 35]. A systematic review of antimicrobial 
prescription in the WHO African region showed that 
private facilities were more likely to provide antimicro-
bials without necessary clinical assessment in order to 
retain their customer-base [42]. Another concern with 
unregulated private facilities is that some antimicrobi-
als accessed may be substandard and counterfeit [7, 43]. 
Therefore, there is a crucial need for a robust inspection 
and enforcement structure to regulate access to antimi-
crobials in the private sector and ensure adherence to 
existing national guidelines and regulations on antimi-
crobial prescription [35].
The challenge of accessing antimicrobials for animals 
without the necessary diagnosis and prescription was 
evident with farmers heavily reliant on private providers. 
Indeed, the farmers involved in our study mainly accessed 
antimicrobials through private providers including 
mobile veterinary practitioners, as well as veterinary and 
human drug shops. The use of mobile veterinary practi-
tioners, also commonly known as mobile clinics or units 
in LMICs, is an innovative solution to promote access to 
animal health service delivery, especially in rural commu-
nities [44]. Although our study revealed gaps in compe-
tence and practice of the mobile veterinary practitioners, 
past studies involving qualified veterinarians showed 
the provision of quality services. For instance, a recent 
pilot of mobile veterinary clinics in Kenya used trained 
agrovets overseen by government veterinarians [45]. 
The study in Kenya highlights the need to regulate pri-
vate providers of antimicrobials for animal health which 
should be fully embraced in Uganda. The lack of regula-
tions and minimal implementation of existing guidelines 
regarding accessing antimicrobials for animals has impli-
cations for human health through contributing to AMR 
[4]. Therefore, the veterinary capacity of public institu-
tions needs to be strengthened so as to better regulate 
the use of antimicrobials in animal husbandry. Uganda, 
like other LMICs such as Kenya and Nigeria, still lacks a 
strong veterinary health system due to a shortage of vet-
erinary professionals, inadequate funds, and the lack of 
a clear policy framework [45, 46]. The predominant reli-
ance on private actors will continue to grow unless gaps 
in the public sector are addressed. Therefore, there is an 
urgent need for more active government involvement in 
veterinary service provision in Uganda including regula-
tion of private practice.
Despite the challenges faced in accessing antimi-
crobials from public and private facilities, our study 
revealed inappropriate use in humans and animals such 
as self-medication, sharing of antimicrobials among 
family members, incomplete dosage consumption, 
administering human antibiotics in animals, and over-
use of antimicrobials in humans and animals. Inap-
propriate use of antimicrobials is common in LMICs 
and is among the most critical drivers of AMR glob-
ally [31, 32]. The development of AMR from misuse of 
antimicrobials can occur through direct consumption 
or indirectly through the presence of residual anti-
microbials in animal products or in the environment. 
Inappropriate use of antimicrobials has led research-
ers to call for a balance between access and resistance 
[1], as unregulated access drives indiscriminate behav-
iour and practices at individual level [35, 42]. Although 
unregulated access is a crucial enabler of inappropri-
ate consumption of antimicrobials [31], other concerns 
such as cost, literacy level, geographical location, and 
low awareness of AMR are also important [7, 31, 40]. 
For instance, in a study conducted among pastoralists 
in Kasese region of Uganda, 78% of the respondents 
did not know about AMR [47]. Therefore, in addition 
to implementing robust regulatory and surveillance 
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systems, there is a crucial need for increased aware-
ness of appropriate antimicrobial use at community 
level as stipulated in the Uganda AMR NAP [9] and 
WHO recommendations [35].
The participants in our study commonly exhibited 
poor practices in disposing of antimicrobials through 
burning, and dumping with general waste including in 
rubbish pits. Poor disposal of antimicrobials is recog-
nized as a global challenge because antimicrobial resi-
dues in environmental locations such as soil and water 
can drive AMR development [23]. While progress is 
being made in high-income countries by establishing 
national drug disposal systems such as drug return 
for safe disposal, evidence on how this can be imple-
mented and sustained in LMICs is still sparse [23, 24, 
48]. In addition, poor drug disposal practices are asso-
ciated with low awareness of proper disposal mecha-
nisms [23, 26]. Although a study in Ethiopia showed 
high awareness of the environmental impacts of poor 
antimicrobial disposal, there existed a gap between 
knowledge and practice due to the contextual factor of 
lack of a suitable drug disposal system at community 
level [23]. For effective design of antimicrobial waste 
management systems, Environmental Health profes-
sionals need to be involved. Once such systems are in 
place, key stakeholders including human and animal 
health professionals as well as CHWs need to take 
active roles in educating the community on proper 
disposal of antimicrobials. Involving other health pro-
fessions in establishing systems for disposal of antimi-
crobials through multidisciplinary collaboration [34, 
49] will help to address the growing challenge of AMR.
This study was conducted in peri-urban and rural 
settings in Wakiso district, hence the findings may not 
be generalizable to the entire district or country. Wak-
iso district being close to Kampala, the capital city, 
facilitates access to antimicrobials from private facili-
ties particularly for animals. Districts which are fur-
ther from the capital may not have similar access, thus 
the situation regarding access and use of antimicrobials 
in such communities may differ from those presented 
in this study. Use of qualitative methods in our study 
enabled exploration of key issues concerning access 
and use of antimicrobials in the community including 
among humans and animals. Another strength of the 
study was the involvement of a wide range of partici-
pants including community members, farmers and key 
stakeholders at national and sub-national levels which 
enriched the findings. The assessment of antimicrobial 
disposal routes in the community is another strength 
of the study as this has not been fully investigated in 
Uganda and beyond.
Conclusion
Antimicrobials for humans were accessed from the pub-
lic sector including health centres, and private health 
facilities such as drug shops and clinics. For animals, 
antimicrobials were predominantly obtained from vet-
erinary practitioners and drug shops (for both veterinary 
and humans). Inappropriate use of antimicrobials in both 
humans and animals was reported such as sharing anti-
biotics among household members, and giving human-
prescribed antimicrobials to food-producing animals as 
growth promoters. Antimicrobials were most commonly 
disposed of by households with general waste includ-
ing dumping in rubbish pits. There is a need to increase 
awareness among the population on proper access, use 
and disposal of antimicrobials in both humans and ani-
mals to help prevent the further development of AMR 
in communities. In addition, development of a drug dis-
posal system for use in communities is important to facil-
itate improved waste management of antimicrobials.
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